Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MALDI mass spectrometric imaging based identification of clinically relevant signals in prostate cancer using large-scale tissue microarrays.

International journal of cancer - 15 Aug 2013

Steurer Stefan, Borkowski Carina, Odinga Sinje, Buchholz Malte, Koop Christina, Huland Hartwig, Becker Michael, Witt Matthias, Trede Dennis, Omidi Maryam, Kraus Olga, Bahar Ahmad S, Seddiqi A Shoaib, Singer Julius M, Kwiatkowski Marcel, Trusch Maria, Simon Ronald, Wurlitzer Marcus, Minner Sarah, Schlomm Thorsten, Sauter Guido, Schlüter Hartmut

Abstract excerpt

To identify molecular features associated with clinico-pathological parameters and TMPRSS2-ERG fusion status in prostate cancer, we employed MALDI mass spectrometric imaging (MSI) to a prostate cancer tissue microarray (TMA) containing formalin-fixed, paraffin-embedded tissues samples from 1,044 patients for which clinical follow-up data were available. MSI analysis revealed 15 distinct mass per charge...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to TMPRSS2 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Prostatic Neoplasms

Share to Reproducibility of Results

Share to Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Share to Tandem Mass Spectrometry

Share to Tissue Array Analysis

Source

Identifiers

PMID: 23381989
DOI: 10.1002/ijc.28080

Genes

ERG
TMPRSS2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MALDI mass spectrometric imaging based identification of clinically relevant signals in prostate cancer using large-scale tissue microarrays.PMID 23381989Read ↗

Detailed Molecular and Immune Marker Profiling of Archival Prostate Cancer Samples Reveals an Inverse Association between TMPRSS2:ERG Fusion Status and Immune Cell Infiltration.Semantic proximity Read ↗

Mapping Isoform Abundance and Interactome of the Endogenous TMPRSS2-ERG Fusion Protein with Orthogonal Immunoprecipitation-Mass Spectrometry AssaysSemantic proximity Read ↗

TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signalingSemantic proximity Read ↗

Morphological features of TMPRSS2-ERG gene fusion prostate cancer.Semantic proximity Read ↗

Cysteine-Rich Secretory Protein-3 (CRISP3) Is Strongly Up-Regulated in Prostate Carcinomas with the TMPRSS2-ERG Fusion GeneSemantic proximity Read ↗

<i>TMPRSS2:ERG</i> fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosisSemantic proximity Read ↗

Urine TMPRSS2: ERG Fusion Transcript as a Biomarker for Prostate Cancer: Literature ReviewSemantic proximity Read ↗

Mapping of TMPRSS2–ERG fusions in the context of multi-focal prostate cancerSemantic proximity Read ↗

ETS-related gene (ERG) undermines genome stability in mouse prostate progenitors via Gsk3β dependent Nkx3.1 degradationSemantic proximity Read ↗

<i>TMPRSS2</i> : <i>ERG</i> Fusion Identifies a Subgroup of Prostate Cancers with a Favorable PrognosisSemantic proximity Read ↗

Delineation of <i>TMPRSS2-ERG</i> Splice Variants in Prostate CancerSemantic proximity Read ↗

A high-density tissue microarray from patients with clinically localized prostate cancer reveals ERG and TATI exclusivity in tumor cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.